Anticoagulant Management Errors (Warfarin and DOAC) Claims

Overview

What are anticoagulants?

Anticoagulants are a class of medication often referred to as “blood thinners,” although they do not actually make the blood thinner. Instead, they interrupt the chemical process that causes blood to clot. Under normal circumstances, clotting is a healthy response to injury (like a cut on your finger). However, for patients with certain heart conditions or a history of clots, the blood may clot inside the veins or arteries when it shouldn't. This can lead to blockages that cause strokes or heart attacks.

By lengthening the time it takes for a clot to form, these medications significantly reduce the risk of these catastrophic events. Because they affect the body’s natural defence system against bleeding, the management of these drugs must be handled with extreme care. If the blood does not clot easily enough, a patient is at risk of serious internal bleeding. If it clots too easily, the medication is not doing its job. Finding and maintaining this balance is the responsibility of your medical providers.

The difference between Warfarin and DOACs

For many years, the standard anticoagulant used in Ireland was Warfarin. Warfarin is highly effective, but it is also complex to manage. It interacts with many other medicines and even certain foods (like leafy green vegetables). Because its effect can fluctuate wildly, patients on Warfarin require frequent blood tests to ensure their clotting levels remain within a safe range.

In recent years, a newer class of drugs known as DOACs (Direct Oral Anticoagulants) has become very common. You may know these by brand names or generic names such as Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), or Edoxaban (Lixiana). Unlike Warfarin, these drugs are generally prescribed at a fixed dose and do not require the same frequent blood checks to see if they are working. However, they are not risk-free, and they still require specific medical oversight, particularly regarding kidney function.

Why precise dosing and monitoring is critical

Most medications have a wide "margin for error." If you take slightly too much paracetamol, for example, it is unlikely to cause immediate harm. Anticoagulants are different. They have what is known as a narrow therapeutic window.

This means there is a very fine line between the dose required to prevent a stroke and the dose that causes dangerous bleeding.

• Too little medication: The blood remains too "sticky," leaving the patient vulnerable to a stroke or pulmonary embolism (a clot in the lung).
• Too much medication: The blood loses its ability to clot effectively, leading to a high risk of internal bleeding, particularly in the brain or stomach.

Because this window is so narrow, monitoring is essential.

Common settings where these are prescribed

Anticoagulants are prescribed and managed across the entire Irish healthcare system.

• GP Surgeries: General Practitioners are often responsible for repeating prescriptions and overseeing long-term monitoring.
• Hospitals: These drugs are frequently started after a hospital admission for a heart issue or surgery.
• Discharge: The transition from hospital to home is a critical moment where clear instructions must be given.

In Ireland, the Health Service Executive (HSE) and patient safety bodies have clear guidelines on how these high-alert medications should be handled to ensure patient safety. Deviating from these guidelines can result in avoidable harm.

Common anticoagulant management errors

Errors involving anticoagulants rarely happen because a patient intentionally took the wrong pill. They usually happen because the systems designed to keep the patient safe failed. The type of error often depends on whether the patient is taking Warfarin or a newer DOAC, as the management styles are quite different.

Errors specific to Warfarin

Warfarin requires a "hands-on" approach. The dose changes frequently based on blood test results. Because it is so sensitive to changes in diet and other medicines, the medical team must be vigilant.

• Missed INR monitoring: The INR (International Normalised Ratio) is the blood test used to measure how fast blood clots. If a GP or clinic fails to schedule these tests regularly, or fails to react when the results are too high or too low, the patient is left unprotected.
• Dose changes without blood checks: A doctor should rarely change a Warfarin dose without a recent INR result to guide them. Guesswork in dosing can lead to immediate danger.
• Unchecked interactions: Warfarin interacts dangerously with many common antibiotics and herbal supplements. If a doctor prescribes an antibiotic for a chest infection but fails to adjust the Warfarin dose or check the INR, the patient’s risk of bleeding can spike dramatically.
• Unclear discharge instructions: When leaving the hospital, patients need a clear "Yellow Book" or schedule telling them exactly what dose to take each day. Errors here are a common cause of readmission.

Errors specific to DOACs (Apixaban, Rivaroxaban, etc.)

Because DOACs are marketed as being "easier" than Warfarin, there is sometimes a false sense of security. Doctors may fall into a "set and forget" mentality, which is dangerous.

• Wrong dose for the specific condition: The dose of Apixaban used to treat an active clot in the leg is different from the dose used to prevent a stroke in a patient with an irregular heartbeat. Confusing these doses is a significant prescribing error.
• Failure to check kidney function (Renal Function): DOACs are processed by the kidneys. If a patient’s kidney function declines (which is common in older people), the drug can build up in the body, leading to an overdose effect. Doctors must check kidney function annually or more frequently for older patients to ensure the dose is still safe.
• Weight and age factors: Some DOACs require a dose reduction if the patient is over 80 years old or under 60kg in weight. Failing to reduce the dose for a frail, elderly patient significantly increases the risk of a bleed.
• Harmful combinations: Prescribing anti-inflammatories (like Ibuprofen or Naproxen) alongside DOACs significantly increases bleeding risk and should generally be avoided or managed with extreme caution.

Where errors occur along the care pathway

Anticoagulant errors are rarely the fault of a single individual. They are often collective failures that occur when a patient moves between different stages of care. Identifying where the breakdown happened is a key part of investigating these issues.

GP prescribing and repeat prescriptions

For many patients, the GP is the gatekeeper of their medication. A common failure occurs when a patient is placed on a repeat prescription for years without a medication review. If a patient's health changes,for example, they lose a lot of weight or their kidneys weaken,the old dose may become toxic. A GP has a duty to ensure that a prescription is still safe before signing it off again.

Hospital prescribing and medication reconciliation

Hospitals are busy, high-pressure environments where medication lists can get confused.

• Admission Errors: When a patient is admitted through A&E, getting an accurate list of their home medications is vital. If a doctor misses the fact that a patient is on an anticoagulant and prescribes a conflicting drug, the result can be serious.
• Ward Rounds: During a hospital stay, doses might be paused for surgery. Errors occur when the team forgets to restart the medication after the procedure, leaving the patient at risk of developing a clot during recovery.

Discharge and handover

The most dangerous time for medication safety is often the day a patient goes home.

• Communication Gaps: A hospital consultant may change a medication but fail to clearly communicate this to the patient’s GP.
• Summary Errors: Discharge summaries (the letter sent to the GP) often contain typos or omissions. If the hospital tells the GP to continue a drug at the wrong dose, the GP may continue that error for months.

Pharmacy dispensing and care settings

While less common than prescribing errors, mistakes can happen at the point of dispensing.

• Dispensing Errors: A pharmacist may accidentally dispense the wrong strength of tablet (e.g., 5mg instead of 2.5mg).
• Nursing Homes: In residential care, medications are often managed by staff. Errors in blister packs or administration (giving the pill to the wrong resident or at the wrong time) are serious breaches of care standards.

Possible outcomes linked to anticoagulant mismanagement

When anticoagulants are not managed with the required standard of care, the physical impact on the patient is immediate and often severe. The harm falls into two opposing categories: bleeding (too much drug) or clotting (too little drug).

Bleeding complications

If the dose is too high, or if monitoring has been neglected, the blood cannot clot to seal minor vessel damage. This can lead to:

• Gastrointestinal Bleeds: Severe bleeding in the stomach or bowel, often requiring blood transfusions and emergency surgery.
• Intracranial Haemorrhage: This is bleeding inside the brain. It is the most feared complication of anticoagulant therapy. It can occur spontaneously or after a minor bump to the head and can be fatal or life-altering.
• Haematomas: Large, painful collections of blood in the muscles or joints that can cause nerve damage and mobility issues.

Clotting events (Thrombosis)

If the dose is too low, missed, or stopped inappropriately, the patient loses their protection against clots.

• Ischaemic Stroke: A clot travels to the brain, blocking blood supply. This can cause paralysis, speech loss, and loss of independence.
• Pulmonary Embolism (PE): A clot travels to the lungs, causing chest pain and severe difficulty breathing. This is a life-threatening medical emergency.
• Deep Vein Thrombosis (DVT): A clot forms in the deep veins of the leg, causing pain, swelling, and the risk of the clot moving to the lungs.

Secondary health impacts

The harm is not limited to the immediate event.

• Extended Recovery: Patients may face months of rehabilitation, physiotherapy, or speech therapy.
• Loss of Independence: A stroke or severe bleed can mean a patient can no longer live alone or return to work.
• Psychological Impact: The trauma of a preventable medical emergency can lead to significant anxiety and a loss of trust in medical providers.

When an anticoagulant error may amount to clinical negligence

It is important to understand that not every negative outcome is due to negligence.

Anticoagulants carry known risks. A patient can be monitored perfectly, take their medication exactly as prescribed, and still suffer a bleed or a clot. This is an unfortunate side effect of the drug, not necessarily a medical error.

Clinical negligence arises when the care provided fell below the standard expected of a competent medical professional, and that failure directly caused the injury. In Irish law, we look for avoidable errors.

To determine if a case exists, we must assess the care against the legal principles (Dunne Principles) established by the Irish courts. Important considerations include:

• Standard of Care: Would a competent GP or Consultant acting with ordinary care have made the same decision? For example, no competent doctor would prescribe a high dose of Warfarin without checking the INR level.
• Causation: Did the error actually cause the injury? We must prove that if the bloods had been checked or the dose adjusted, the stroke or bleed would likely have been avoided.
• Protocol Violations: Did the medical team ignore established HSE or international safety guidelines regarding the drug?

How these cases are typically investigated

Investigating a medication error requires a forensic examination of the medical records such as:

• GP and Hospital Records: We review the medication administration records (Kardex) to see exactly what was given and when.
• Blood Test Timelines: We map out the dates of blood tests (INR, kidney function) against the dates of prescriptions. We look for long gaps where monitoring should have happened but didn't.
• Discharge Letters: We compare what the hospital intended the patient to take versus what was actually prescribed by the GP or dispensed by the pharmacy.
• Independent Expert Opinion: This is the most critical step. We engage independent experts (often Consultant Haematologists or General Practitioners) to review the file. They provide an objective opinion on whether the management of the medication fell below the acceptable medical standard.

Time limits and procedural route in Ireland

If you are considering investigating a potential error, it is vital to be aware of the strict time limits that apply to medical negligence cases in Ireland.

Generally, the Statute of Limitations is two years. This clock usually starts ticking from the date the injury occurred, or the "Date of Knowledge",the date you first realised (or should have realised) that the injury might be due to a medical error. Because determining the "Date of Knowledge" can be legally complex, it is safer to act sooner rather than later.

It is also important to note that the Injuries Resolution Board (formerly PIAB) does not assess medical negligence claims. Unlike a car accident or a workplace injury, these cases are too complex for the Board's assessment process. These matters are dealt with through the litigation process, typically in the Courts, which is why specialist legal advice is necessary from the outset.

Practical steps if you are concerned about an error

If you or a family member has suffered a bleed or a clot and you suspect it may be linked to medication management, there are immediate steps you can take to protect your health and your potential legal position.

• Seek urgent medical review: If you have symptoms of bleeding (bruising, dark stools) or clotting (swelling, shortness of breath), go to the Emergency Department immediately.
• Preserve the evidence: Keep the packaging of the medication, any blister packs, and any "Yellow Books" or dosage instruction letters you have at home.
• Request your records: You have a right to request a copy of your medical file from your GP and hospital under Freedom of Information or Data Protection acts.
• Write down a timeline: While your memory is fresh, write down the dates of appointments, what was said about dose changes, and when you started feeling unwell.

FAQs

Can a medication interaction involving Warfarin be prevented?

Yes. Doctors and pharmacists have access to databases that flag interactions. Before prescribing a new drug (like an antibiotic), they should check if it interacts with Warfarin. If it does, they should either choose a different drug or monitor your bloods much more closely.

What does “monitoring” actually mean for these drugs?

For Warfarin, monitoring means regular blood tests (INR) to check clotting speed. For DOACs (Apixaban, etc.), monitoring means checking your kidney function (blood test) and weight at least once a year, or more often if you are frail or unwell, to ensure the dose is still safe.

Are DOACs dosed differently depending on the patient?

Yes. The standard dose might be too strong for someone with reduced kidney function, low body weight, or advanced age. A "one size fits all" approach is often incorrect and can be dangerous.

How long do medical records requests typically take?

Under GDPR and Freedom of Information rules, healthcare providers usually have one month to respond to a request for records, though this can sometimes be extended to two or three months in complex cases.

Does the Injuries Resolution Board handle medication errors?

No. The Injuries Resolution Board (formerly PIAB) does not deal with claims arising from medical negligence. These cases are handled directly by solicitors and the Courts system.

Can I claim if I had a bleed but recovered fully?

If the bleed was caused by negligence and resulted in pain, suffering, hospitalisation, or financial loss (like lost wages), you may have a valid case, even if you eventually made a full recovery.

Seeking Answers and Accountability

When you take a medication prescribed by your doctor, you expect it to make you better, not worse. Anticoagulants are powerful, necessary drugs, but they demand a level of professional care and monitoring that is not negotiable.

If you believe that you or a loved one suffered a stroke, a serious bleed, or other complications due to errors in medication management, you likely need answers. It can be difficult to know if what happened was an unavoidable side effect or a preventable error.

At Michael Boylan LLP, we specialise in unravelling these complex medical histories. We approach every inquiry with empathy and a dedication to finding the truth. We can help you access your medical records, secure independent expert opinion, and determine if the standard of care you received was adequate.

Contact our team today for a confidential, no-obligation discussion about your experience.

*In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.